Form 8-K Amphastar Pharmaceutical For: Mar 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at BMO Capital
March 13, 2019 6:36 AM EDTBMO Capital analyst Gary Nachman raised the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $23.00 (from $21.00) while maintaining a Market Perform rating.
4Q18 results were good overall, although the quarter did benefit from a couple of one-timers (Enoxaparin and insulin API).Management... More